VVOS

VVOS

USD

Vivos Therapeutics Inc. Common Stock

$2.684-0.006 (-0.204%)

Preço em tempo real

Healthcare
Dispositivos médicos
Estados Unidos

Gráfico de preços

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$2.690

Máximo

$2.690

Mínimo

$2.600

Volume

0.00M

Fundamentos da empresa

Capitalização de mercado

16.3M

Setor

Dispositivos médicos

País

United States

Estatísticas de negociação

Volume médio

0.12M

Bolsa de valores

NCM

Moeda

USD

Faixa de 52 semanas

Mínimo $1.91Atual $2.684Máximo $6.28

Notícias relacionadas

GlobeNewswire

Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada

By acquiring The Sleep Center of Nevada, Vivos expands its business model to make its OSA treatments available to thousands of patients in the greater Las Vegas metro area Acquisition expected to close later this

Ver mais
Vivos Therapeutics Signs Definitive Agreement to  Acquire Largest Sleep Center Operator in Nevada
Analyst Upgrades

Ascendiant Capital Maintains Buy on Vivos Therapeutics, Lowers Price Target to $6.2

Ascendiant Capital analyst Lucas Ward maintains Vivos Therapeutics with a Buy and lowers the price target from $6.6 to $6.2.

Ver mais
Ascendiant Capital Maintains Buy on Vivos Therapeutics, Lowers Price Target to $6.2
GlobeNewswire

Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update

Year over year product revenue increased 26% Operating expenses declined 21% and year over year operating loss decreased 35% Management to Host Conference Call today at 5:00 pm ET LITTLETON, Colo., March 31,

Ver mais
Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update
GlobeNewswire

Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call

LITTLETON, Colo., March 28, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ:VVOS), a leading medical device and technology company specializing in the development and

Ver mais
Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call

Mantenha-se atualizado

Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.